- Report
- April 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- April 2025
- 50 Pages
Global
From €2412EUR$2,650USD£2,068GBP
- Report
- April 2025
- 50 Pages
Global
From €2412EUR$2,650USD£2,068GBP
- Report
- March 2025
- 185 Pages
Global
From €3226EUR$3,545USD£2,766GBP
€3585EUR$3,939USD£3,073GBP
- Report
- April 2025
- 578 Pages
Global
From €5324EUR$5,850USD£4,564GBP
- Report
- April 2025
- 189 Pages
Global
From €5324EUR$5,850USD£4,564GBP
- Report
- March 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- March 2025
- 175 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- February 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- September 2024
- 145 Pages
Global
From €2729EUR$2,999USD£2,340GBP
- Report
- May 2024
- 140 Pages
Global
From €5915EUR$6,499USD£5,071GBP
- Report
- December 2024
- 84 Pages
Global
From €3595EUR$3,950USD£3,082GBP
- Report
- July 2024
- 150 Pages
Global
From €3413EUR$3,750USD£2,926GBP
- Clinical Trials
- August 2024
- 60 Pages
Global
From €1138EUR$1,250USD£975GBP
- Report
- February 2025
- 183 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- March 2025
- 210 Pages
Global
From €4546EUR$4,995USD£3,897GBP
- Report
- February 2025
- 130 Pages
Global
From €3973EUR$4,365USD£3,406GBP
€4414EUR$4,850USD£3,784GBP
- Report
- November 2024
- 90 Pages
North America
From €3140EUR$3,450USD£2,692GBP
- Report
- November 2024
- 84 Pages
Middle East, Africa
From €3140EUR$3,450USD£2,692GBP
- Report
- November 2024
- 90 Pages
Europe
From €3140EUR$3,450USD£2,692GBP

Oxycodone is an opioid analgesic medication used to treat moderate to severe pain. It is a semi-synthetic opioid derived from thebaine, an alkaloid found in the opium poppy. Oxycodone is available in both immediate-release and extended-release formulations, and is commonly prescribed in combination with other analgesics such as acetaminophen or ibuprofen. Oxycodone is one of the most widely prescribed analgesics in the United States, and is used to treat a variety of conditions including chronic pain, post-operative pain, and cancer-related pain.
Oxycodone is a key player in the analgesic market, and is often used in combination with other analgesics to provide more effective pain relief. It is also used in combination with non-opioid analgesics such as non-steroidal anti-inflammatory drugs (NSAIDs) to reduce the risk of opioid-induced side effects. Oxycodone is available in both generic and brand-name formulations, and is available in a variety of dosage forms including tablets, capsules, and oral solutions.
Some companies in the Oxycodone market include Purdue Pharma, Endo Pharmaceuticals, Teva Pharmaceuticals, and Mylan Pharmaceuticals. Show Less Read more